GlassScriptPhysician profile
Marguerite E Katt
NPI 1588814784
$3,728.68
in general payments reported to CMS, 2019-2025
11 companies · $686 in 2025
The $686 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $736 · 2022: $522 · 2023: $1,064 · 2024: $721 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,452 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.44 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,415.53 | 2021-2025 | Avvigo Guidance System, Rotapro, Opticross |
| Medtronic, INC. | $856.41 | 2021-2025 | Micra, Symplicity G3, Linq II |
| Abbott Laboratories | $493.91 | 2022-2025 | Aveir, Ensite |
| Chiesi USA, INC. | $244.36 | 2021-2025 | Kengreal |
| Shockwave Medical, INC | $196.23 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Astrazeneca Pharmaceuticals LP | $167.45 | 2021-2024 | Brilinta, Farxiga |
| Impulse Dynamics (USA) INC. | $135.59 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $121.03 | 2021-2024 | Xarelto |
| Edwards Lifesciences Corporation | $59.44 | 2024-2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $23.79 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.94 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marguerite Katt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.